Janney Montgomery Scott
TXMD icon

Janney Montgomery Scott’s TherapeuticsMD TXMD Stock Holding History

Janney Montgomery Scott’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,951
Closed -$357K – 2095
2019
Q4 		$357K Buy
+2,951
New +$424K ﹤0.01% 1619
2017
Q2 		– Sell
-1,157
Closed -$416K – 1806
2017
Q1 		$416K Buy
1,157
+534
+86% +$165K 0.01% 1246
2016
Q4 		$180K Buy
+623
New +$193K ﹤0.01% 1563

Other funds holding TXMD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janney Montgomery Scott's TXMD Position: Q1 2020 in Review

Janney Montgomery Scott sold out of TherapeuticsMD (TXMD) in Q1 2020, closing a stake of 2,951 shares — an estimated $357K sold.

Janney Montgomery Scott first reported a position in TXMD in Q4 2016 and held it in 3 quarters. The position peaked at $416K in Q1 2017. 143 funds tracked by Wall St. Rank hold TXMD as of Q1 2020.

  • Janney Montgomery Scott reported no remaining TherapeuticsMD position as of Q1 2020 after selling out during the quarter.
  • Janney Montgomery Scott sold 2,951 TherapeuticsMD shares in Q1 2020, an estimated $357K.
  • Janney Montgomery Scott first reported a position in TherapeuticsMD in Q4 2016 and held it in 3 quarters.
  • Janney Montgomery Scott's TherapeuticsMD position peaked at $416K in Q1 2017.
  • 143 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2020.

Based on Janney Montgomery Scott's 13F filing for Q1 2020, filed 30 Apr 2020.